Aqueous Humor Antioxidants in Glaucoma: Correlations With Subtypes, Intraocular Pressure, and Medication Use-A...

Ocular health depends heavily on the balance between pro-oxidant forces and the protective mechanisms found within the anterior segment. Prior research has shown that the aqueous humor serves as a vital medium for delivering nutrients and removing metabolic waste from avascular tissues. This fluid contains a complex array of molecules designed to neutralize reactive oxygen species that contribute to trabecular meshwork dysfunction. While the role of oxidative stress in retinal ganglion cell apoptosis is well-documented, the specific variations in defensive capacity across different hypertensive etiologies remain unclear. Scientists have long debated whether the depletion of these protective resources is a cause or a consequence of elevated internal eye pressure. The relationship between pharmacological treatments and the overall redox status of the eye also remains a subject of active scientific inquiry. This absence of evidence motivated a detailed investigation into how diverse disease classifications and pressure histories affect the total scavenging potential of the ocular environment.

This prospective clinical study sought to characterize the relationship between the Total Antioxidant Capacity (TAC) of the aqueous humor and various diagnostic classifications of glaucoma. The investigators aimed to determine if specific subtypes, such as Primary Open-Angle Glaucoma (POAG) or Neovascular Glaucoma (NVG), showed distinct biochemical profiles. Another primary goal involved assessing the correlation between these protective levels and the history of maximal Intraocular Pressure (IOP) recorded for each patient. The research team also focused on identifying how fluctuations in pressure over time might influence the concentration of Ascorbic Acid (AA) and other scavenging agents. The study evaluated the potential impact of long-term pharmacological interventions on the antioxidant status of the anterior chamber fluid. By examining these variables, the researchers intended to provide a clearer understanding of the biochemical factors contributing to the progression of ocular hypertensive diseases. This work aims to identify potential biomarkers that could guide future therapeutic interventions for high-risk patient groups.

The research team conducted a prospective case-control study involving a cohort of 303 patients who underwent cataract surgery at a specialized facility. Participants were enrolled between April 2019 and September 2024 and categorized into groups representing Primary Open-Angle Glaucoma (POAG), Primary Angle-Closure Glaucoma (PACG), Neovascular Glaucoma (NVG), and Uveitic Glaucoma (UG). During the surgical procedure, clinicians carefully aspirated samples of the aqueous humor from the anterior chamber before any other intraocular maneuvers occurred. These specimens were immediately processed to quantify the Total Antioxidant Capacity (TAC) and the specific levels of Ascorbic Acid (AA) using standardized laboratory protocols. The statistical framework used multivariate linear regression to account for confounding variables while exploring the links between biochemical markers and clinical history. Analysts specifically scrutinized the data for associations with maximal Intraocular Pressure (IOP) values and the magnitude of pressure variations observed during the follow-up period. This comprehensive approach allowed for the identification of independent factors influencing the ocular redox state.

The analysis revealed that patients diagnosed with Uveitic Glaucoma (UG) possessed the highest concentrations of Total Antioxidant Capacity (TAC) within their aqueous humor. Following this group, individuals with Primary Open-Angle Glaucoma (POAG) and Primary Angle-Closure Glaucoma (PACG) showed intermediate levels of these protective molecules. Conversely, the lowest scavenging potential was observed in the Neovascular Glaucoma (NVG) cohort, with statistical significance established at P < 0.001. Multivariate regression models indicated that TAC levels were significantly linked to the history of maximal Intraocular Pressure (IOP), yielding a beta coefficient of -0.013. The researchers also identified a significant negative correlation between antioxidant levels and the degree of IOP fluctuations (β = -0.016; 95% Confidence Intervals [CI], -0.027 to -0.004; P = 0.007). No evidence was found to suggest that the use of various glaucoma medications influenced the biochemical defense markers in the anterior chamber. These findings provide a detailed map of how different ocular conditions impact the internal protective environment of the eye.

The study concludes that both the specific subtype of glaucoma and the dynamics of intraocular pressure significantly dictate the antioxidant status of the aqueous humor. These findings highlight a significant variation in the ocular microenvironment that may influence how different patients respond to elevated pressure. The researchers propose that Total Antioxidant Capacity (TAC) plays a functional role in the underlying pathophysiology of the disease and could serve as a viable therapeutic target. Future clinical trials might focus on delivering targeted antioxidant therapies to patients with PACG or NVG, who typically exhibit lower defensive levels. Individuals with a history of highly fluctuating or severely elevated pressure may benefit from interventions designed to bolster their ocular scavenging resources. This research provides essential data for the development of personalized treatment strategies aimed at mitigating oxidative damage in high-risk glaucoma populations. Ultimately, these insights contribute to a more nuanced understanding of the metabolic challenges faced by the glaucomatous eye.